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Background: The harmful side effects of electroporation to cells due to local
changes in pH, the appearance of toxic electrode products, temperature increase,
and the heterogeneity of the electric field acting on cells in the cuvettes used for
electroporation were observed and discussed in several laboratories. If cells are
subjected to weak electric fields for prolonged periods, for example in experiments
on cell electrophoresis or galvanotaxis the same effects are seen. In these
experiments investigators managed to reduce or eliminate the harmful side effects
of electric current application.
Methods: For the experiments, disposable 20 μl cuvettes with two walls made of
dialysis membranes were constructed and placed in a locally focused electric field at
a considerable distance from the electrodes. Cuvettes were mounted into an
apparatus for horizontal electrophoresis and the cells were subjected to direct
current electric field (dcEF) pulses from a commercial pulse generator of
exponentially declining pulses and from a custom-made generator of double and
single rectangular pulses.
Results: More than 80% of the electroporated cells survived the dcEF pulses in both
systems. Side effects related to electrodes were eliminated in both the flow through
the dcEF and in the disposable cuvettes placed in the focused dcEFs. With a
disposable cuvette system, we also confirmed the sensitization of cells to a dcEF
using procaine by observing the loading of AT2 cells with calceine and using a
square pulse generator, applying 50 ms single rectangular pulses.
Conclusions: We suggest that the same methods of avoiding the side effects of
electric current pulse application as in cell electrophoresis and galvanotaxis should
also be used for electroporation. This conclusion was confirmed in our
electroporation experiments performed in conditions assuring survival of over 80% of
the electroporated cells. If the amplitude, duration, and shape of the dcEF pulse are
known, then electroporation does not depend on the type of pulse generator. This
knowledge of the characteristics of the pulse assures reproducibility of
electroporation experiments using different equipment.
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Cell electroporation is used in many research laboratories and clinics [1–4]. Reversible
electroporation is applied to introduce into cells substances which do not normally pass
through cell membranes such as fluorescent dyes, peptides, RNA, antigens and genes
[5–7]. In medicine, reversible and irreversible electroporation of cells and tissues is ap-
plied for drug delivery and tumor ablation [8–18].
We previously published a description of a modification of the method for electro-
poration. It was based on cell suspension flowing through a localized, focused, direct
current electric field (dcEF). We observed that cells are sensitized to the pulsed dcEF
when preincubated with presence of cationic dyes and local cationic anesthetics (e.g.,
lidocaine or procaine). This method has proven useful in experiments when electropor-
ation of a large volume of cell suspension (more than 1 ml) is required and for quantita-
tive research concerning the efficiency of cell electroporation and cell survival [17–21].
However, often only small samples of cell suspension (less than 100 μl) and only small
amounts of substances introduced into cells are available for experiments. In particu-
lar, the amounts of RNA, DNA or antibodies introduced into cells are generally very
limited [22–26].
Our goal was to develop a method for the preparation of disposable, simple electro-
poration cuvettes which can be easily inserted into commercial apparatus for horizontal
electrophoresis. The construction of cuvettes and their placement in focused dcEFs was
intended to avoid the dcEF pulse application side effect that commonly occur when
commercially available cuvettes are used, and thus to ensure higher levels of survival of
reversibly electroporated cells.Methods
Chemicals
Reagents were obtained from the following suppliers: 9-aminoacridine (9-AAA), eth-
idium bromide, diacetate fluorescein, Alexa Fluor 488 Phalloidin, gentamicin, calcein,
Lucifer yellow, phenol red; toluidine blue, lidocaine HCl, procaine HCl, tetracaine HCl
and trypsin-EDTA from Sigma; fetal bovine serum (FBS) from Gibco, Invitrogen; carbo-
xyfluorescein from Fluka-biochemist; culture medium RPMI 1640 with L-glutamine
from Lonza; NaCl and sucrose from Merck; and phosphate-buffered saline (PBS) with-
out calcium and magnesium ions and with calcium and magnesium ions from Biomed.Cells
Experiments were carried out on the well-characterized AT-2 rat prostate cancer cell
line. Cells were grown in 25-cm2 Sarstedt flasks as described previously. For some of
the experiments, normal human skin fibroblasts (HSF) were used [20, 27].
Before electroporation, the cells were washed in Ca2+- and Mg2+-free PBS via centri-
fugation, then suspended in an electroporation solution. The electroporation solution
was 9.5% sucrose and PBS with Ca2+ and Mg2+ at a ratio of 19:1, unless stated
otherwise.
In the sensitization experiments, cells were incubated in an electroporation solution
containing 10 mM procaine HCl for 10 min. Following incubation, the cells were cen-
trifuged for a second time and re-suspended in the electroporation solution. The
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cells to anesthetic-free and fluorescent dye-free media.Cell viability examination
Electroporation was carried out in a solution containing calcein, carboxyfluorescein or
Lucifer yellow. The effectiveness of the method was established by scoring the number
of fluorescent cells 15–30 min after electroporation.
A fluorescent viability test using fluorescein diacetate (FDA) and ethidium bromide
(EtBr) was used to determine the number of live cells [20, 28–30]. During the electro-
poration procedure, the electroporated cells remained in the electroporation medium
with or without added substances for no more than one hour. The cells were then
transferred either to PBS or to the cell culture medium for examination under a fluor-
escence microscope. In each experiment 1250 to 2250 cells were examined under a
Jenavert epi-fluorescent microscope (Carl Zeiss Jena) to determine the effect of the
dcEFs for the desired exposure time. That meant that at least 250 cells were observed
to determine the position of one point in the data plot.
Green fluorescent cells were counted as living and red fluorescent cells as dead with
the FDA/ethidium bromide iodide test. Cells that showed uptake of calcein, carboxyflu-
orescein or Lucifer yellow were counted as reversibly electroporated, while cells that
were not fluorescent were counted as not reversibly electroporated.Cell electroporation system
The experiments were carried out with the system shown in Fig. 1. It consists of a
standard apparatus for horizontal electrophoresis (EP 1201-1EA, Sigma-Aldrich), a
dcEF pulse generator (Gene Pulser II, BioRad) or a custom-made double pulse gener-
ator, power supply cords, exchangable plexiglass cuvettes with walls made of dialysis
membrane, a plexiglass barrier (3 mm thick) with an orifice for placing the electropor-
ation cuvettes, and probe electrodes situated at two sides of the barrier and connected
to a voltmeter (Multimeter G-1004.500, RTF). The disposable cuvettes inserted into the
barrier had a volume of 20 μl and a depth across of 1 mm (Fig. 1).
The cell suspension was introduced into the cuvettes from above. The electropor-
ation cuvette placed in the barrier was immersed in the same electroporation buffer in
which cells were suspended.
The electric field was focused across the cuvette containing the cell suspension and
measured in each series of experiments. Depending on the buffer solution and its vol-
ume, the dcEF across the cuvette was 50 to 60% of the voltage applied to the electrodes
of the apparatus. The duration of cell suspension exposure to high dcEFs was set on
the Gene Pulser II or single and double pulse generator, and the shapes of the pulses
were checked with an oscilloscope (Fig. 2).pH measurement
The pH measurements were conducted in experimental setup consisting of a standard
horizontal electrophoresis apparatus and a strip of electrophoresis paper. Phenol red
was added to the tested solution at a concentration of 10 mg/100 ml as a pH change
indicator. This solution contains a pH indicator which helps in monitoring pH changes
Fig. 1 Experimental system. a – Electroporation cuvette made from plastic and dialysis membrane. (1)
Electroporation cuvette made from plastic. (2) Canal through which cell suspension is inserted into a
pocket. (3) Pocket in which the cell suspension is electroporated. Scale bar = 10 mm. b – Electroporation
cuvette (2) inserted in the plexiglass barrier (1) in the electrophoresis apparatus. Scale bar = 10 mm. c –
Diagram of the experimental setup applied for cell electroporation in an electroporation cuvette in a
localized dcEF. (1) Transverse barrier made of plexiglass with a 19-mm diameter gap for inserting the
electroporation cuvette with the cell suspension. (2) Electroporation cuvette made from plexiglass (a) and
dialysis membrane (b) from Sigma dialysis tubes. (3) Power supply cords with plugs connected to the
electrophoresis apparatus. (4) Probe electrodes situated at two sides of the barrier and connected to a
voltmeter (Multimeter G-1004.500, RFT) to measure dcEF strength across the barrier. (5) The external
solution in which the electroporation cuvette is immersed
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transition from yellow to red over the pH range 6.8 to 8.2. Above pH 8.2, phenol red
turns a bright pink (fuchsia) color.
Two electrode chambers in the apparatus were filled with different volumes of the
tested solutions with phenol red and connected by a strip of paper which was earlier
soaked in a given solution. The pH of each solution and the change in pH after 10 min
of electric field generation were measured using a pH meter (pH-METR CP-511,
Elmetron). The electric field was created between chambers by the direct current
electric field generator connected to electrophoresis apparatus.
The change in pH in the electrode chambers in the electrophoresis apparatus was
observed as the change in color of the phenol red. During the experiment, the current
intensity was measured using a voltmeter (Multimeter G-1004.500, RFT). Photos of the
solution color changes were also taken using the 13 MPx camera of a smartphone
(HTC M9 Prime Camera Edition, HTC) before using the electric field (control photo),
after 5 min and after 10 min.Statistical analysis
Statistical significance was determined using the non-parametric Mann-Whitney U-test
with p < 0.01 considered to indicate significant differences.
Fig. 2 Different forms of electric pulses. Exponentially decaying electric pulse generated by Gene Pulser II. a – 20 V, 80 ms.
b – 50 V, 80 ms. Square wave pulse generated by square and double pulse generator. c – 10 V, 80 ms. d – 20 V, 80 ms
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The principles of avoiding harmful side effects during electroporation
Electroporation methods for introducing substances that do not normally penetrate cell
membranes into cells were developed in the 1970s and 80s and have since found wide ap-
plication. They allow the effective introduction of proteins, DNA, RNA, fluorescent dyes
and drugs into cells and tissues [1–4]. However, difficulties remain in obtaining reprodu-
cible results and preserving good cell viability during reversible electroporation. Recently
published papers showed that electroporated cells die due to the many side effects associ-
ated with pulse dcEF application. Most of these harmful side effects can be avoided using
a method based on the flow of cells through a locally focused electric field [11].
With commercially available electroporation cuvettes, the curves for electroporation ef-
ficiency and cell viability intersect, dependent on the intensity (amplitude), duration or
number of the electric dcEF pulses. The same phenomena are often observed when cell
electroporation is performed on microchips [25, 31–33]. With cell flow through a focused
electric field, these curves are separated and more than 80% of effectively electroporated
cells survive. This is illustrated in Fig. 3.Fig. 3 Uptake of Alexa Fluor 488 Phalloidin by AT2 cells exposed to a dcEF in a flow-through electroporation
system with a localized electric field
Fig. 4 Change in the pH of a 0.9% NaCl solution after treatment with a 300 V electric current (10.9 mA)
Grys et al. Cellular & Molecular Biology Letters  (2017) 22:1 Page 6 of 13When introducing DNA, RNA, proteins and drugs into cells, small volume elec-
troporation cuvettes are used due to the limited availability of material and the
small volume of available cell suspensions. Commercially available electroporation
cuvettes typically have a volume of about 100 to 200 μl. If electrodes are in direct
contact with the cell suspension, the side effects of dcEF action on cells and sus-
pension fluids are not avoided. The experiments described here aimed to establish
experimental conditions that avoid or reduce the side effects of cell electroporation
when using small volume (20 μl) electroporation cuvettes.
Side effects with a significant impact on electroporated cells include:
1. Temperature changes associated with the Joule’s heat produced by the electric
current flowing through the solution
2. pH changes in the solution in which the electrodes used to apply dcEF pulses are
immersed in
3. Changes in electric field strength over time and in the conductivity of the solution
during pulse administration, accompanied by non-uniform distribution of the elec-
tric field in the electroporation cuvette, despite the constant voltage applied to the
electrodes
4. The formation of substances that are toxic for cells at the electrodes
All these phenomena occur whenever the electrodes are immersed in the electrolyte
remaining in direct contact with the cells. Thus, they occur not only during electropor-
ation or electrofusion of cells when pulses of dcEFs are applied, but also during electro-
phoresis of cells and proteins or cell galvanotaxis. However, they occur more slowly,
thus permitting electrochemical and physical analysis. The conclusions of such studies
are directly relevant to research on cell electroporation, where the same phenomena
occur very quickly and in small volumes of liquids. The use of very high voltage applied
to electrodes placed close to the electroporated cells and immersed in the same solu-
tion as the cells increases the severity of such side effects.
In previous research on cell electrophoresis and galvanotaxis, the side effects of electri-
city applied to cells have been decreased and eliminated with the following precautions:
1. The heating of the solution during the flow of electric current has been decreased
by lowering the conductivity of the solution and decreasing electrolyte
concentration (maintaining a constant direct current electric field) or by removing
heat to cooling jackets [20, 34, 35].
Table 1 Change in the pH of a 0.9% NaCl solution after 10 min treatment with a 200 V electric
current according to volume solution in electrode chamber (paper strip 20 mm)
pH at a given time
Volume of 0.9%
NaCl (ml) in the
electrode chamber
Cathode Anode
0 min 10 min 0 min 10 min
15 7.3 12 7.3 2.2
25 7.3 11.3 7.3 2.7
50 7.3 11.4 7.3 3
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influence the thresholds of cell response to the electric field [20, 36, 37]. The reduction
in thermal effects is important in all cell electroporation experiments [38, 39]. In the
experimental system for electroporation described here, besides decreasing the
conductivity of the cell suspension, the electroporation cuvettes are submerged in a
large volume of solution through which no current or low density current flows, and
thus in which heat production is negligible [20].
2. In systems for cell electrophoresis or galvanotaxis, the harmful side effects of toxic
substances produced by the electrodes (metal ions, bubbles of gas, pH changes, etc.)
are eliminated by placing electrodes at a distance from the cuvettes in which the cells
are suspended and focusing the dcEF in these cuvettes. The application of reversible
Ag/AgCl electrodes instead of platinum, aluminum or stainless steel electrodes also
reduces the formation of toxic products. Another method to eliminate the effects of
electrode products on cells is to place filters (agar bridges) between the cuvettes in which
cells are observed and exposed to dcEFs and the electrode chambers [36, 39–41].
3. During the application of an electric field to cells, changes in pH and conductivity
occur in the solution despite the stability of the voltage applied to the electrodes.
Even in systems with simple geometry such as rectangular cuvettes or a cylinder
with constant cross-sections, one cannot specify the local electric field in a solution
by dividing the voltage applied to the electrodes by the distance between electrodes
[36, 42]. When irreversible electrodes are used (e.g., stainless steel, platinum,
aluminum), the distribution of the electric field changes over time due to
polarization of the electrodes. As time passes, a voltage drop begins to occur at the
electrodes and reduces the electric field within the cuvette. These processes can be
observed in systems where such electrodes and solutions of low conductivity are
used. These phenomena also take place in systems used for cell electroporation.
Changes resulting from the polarization of electrodes can be prevented with
reversible electrodes, such as Ag/AgCl electrodes, and/or by placing the cells in able 2 Change in the pH in different solutions after treatment with a 200 V electric current
aper strip 2 mm)
pH at a given time
lution Cathode Anode
0 min 10 min 0 min 10 min
banowski’s solution 7.2 7.2 7.2 7.2
ctroporation solution 7.3 7.4 7.3 6.5
Table 3 The viability of AT2 cells estimated using the EtBr/FDA test after one hour in Łabanowski’s
solution




Cathode solution + anode solution 97.9
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actual local electric field in the cuvette can be estimated using probe electrodes
placed near the cuvette or by calculating the electric field from Ohm’s law. The
local electric field in a variable geometry cuvette depends on the current intensity
and the cross-sectional area through which the current flows according to Ohm’s
law. When the current flowing through the system is constant (I = constants),
the local strength of the electric field (V/cm) depends on the cross-sectional area
through which the current flows. The smaller the cross-sectional area, the greater
the local electric field at constant voltage applied to electrodes and at constant
current intensity (in mA). Both methods have been studied for electrophoresis and
galvanotaxis and given consistent results [20, 42].
4. Only recently have the harmful effects of local pH changes in the solution between
the electrodes been investigated. It was demonstrated that in microchips these
effects reduce cell survival in the vicinity of electrodes.
Łabanowski’s solution: cathode (pH = 7.2) – 15% sacharose, 3.3 mM Hepes, 6.7 mM
TEA, 17.1 mM NaCl; anode (pH = 7.2) – 7% sacharose, 10 mM Hepes, 17.1 mM NaCl.
Electroporation solution (pH = 7.3) – 9.5% sacharose + PBS without Ca2+ and Mg2+ in a
19:1 ratio.
There were attempts to minimize these local pH changes in the solution by increas-
ing the concentration of buffer (i.e., the buffering capacity of the buffer solution) and
determining the effect of pH on cell viability [25, 32, 33]. The pH changes in the solu-
tion under the influence of an electric current and the electrodes were tested previouslyFig. 5 Viability of AT2 cells in a DC electric field in the flow-through system or cuvette system for 80 ms
Fig. 6 AT2 prostate cancer cell loading with calcein following a single 80 ms exposure to dcEF. a – Electroporation
cuvette system. b – Flow-through electroporation system
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fer and the size of the electrodes and the electrolyte concentration in the solution all
reduce and slow changes in the pH of the solution in the vicinity of the electrodes, but
do not eliminate them.
This problem was considered in detail in Łabanowski’s 1979 doctoral dissertation on
cell electrophoresis [43]. He showed that the pH change mainly occurs due to differ-
ences in the electric charge transferring numbers of ions in various buffers and that it
is not possible to eliminate changes in pH at the cathode and anode using a single buf-
fer solution. Consequently, he developed appropriately selected buffers for the anodic
and cathodic chambers to stabilize the pH near the electrodes for a few hours despite
the ongoing flow of current through the solution.
To illustrate this, we ran appropriate experiments in the system in horizontal electro-
phoresis. The Sigma electrophoresis apparatus was used in our experiments. Our re-
sults (Tables 1 and 2, Fig. 4) confirmed Łabanowski’s conclusion. As observed later in
experiments on cell galvanotaxis, these buffers provide stability of pH even when an
electric current is applied for several hours. Moreover, the cells in the electrode buffers
suggested by Łabanowski for anode and cathode solutions ensured cell survival for sev-
eral hours (Table 3).Fig. 7 Electroporation (a – Lucifer yellow, b – carboxyfluorescein) of AT2 cells in a DC electric field for 9 ms
in a solution of 6.75% sucrose + 5.3% PBS + 0.2% NaCl (1 mm) in a cuvette electroporation system
Fig. 8 Electroporation of AT2 cells (calcein) in a DC electric field in the presence or absence of 10 mM
procaine for 50 ms (square wave pulse generator) in a cuvette electroporation system
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In the first series of experiments, we examined the survival of cells suspended in disposable
electroporation cuvettes, placed in locally focused electric fields, and treated with dcEF
pulses of amplitude up to 1000 V cm with a pulse duration of 80 ms. These conditions pro-
vide effective electroporation of most eukaryotic cells with a diameter greater than 5 μm,
shown with the method of cell suspension flow through a focused electric field in (Fig. 5).
More than 90% of the electroporated cells survived such dcEF pulses in both systems thanks
to the elimination of side effects related to the electrodes.
In subsequent experiments, we compared the loading of AT2 cells with calcein via
the application of 80 ms pulses of a dcEF varying in intensity in the flow through field
and in the disposable cuvettes placed in a focused electric field (Fig. 6). In both cases, a
pulse intensity of less than 500 V/cm caused the loading of more than 80% of cells.
Similar results were obtained by loading AT2 cells with Lucifer yellow or carboxyflu-
orescein in the cuvette electroporation system (Fig. 7).
Using the disposable cuvette system, we also confirmed the sensitization of cells to a
dcEF by procaine [23] by observing the loading of AT2 cells with calcein and using a
square pulse generator, applying 50 ms single rectangular pulses (Fig. 8). In this case,
more than 90% of cells were effectively electroporated and loaded with calcein.Conclusions
Direct contact of the electrodes with a small volume of liquid in which the cells are
placed is harmful to cells, which are killed not only by the electric field acting on them
but also indirectly, due to other side effects. Our results suggest that experiments con-
cerning electroporation and electrofusion of cells should not be conducted in isolation
from other research on the effects of electric current and electric fields on cells, in phe-
nomena such as galvanotaxis or cell electrophoresis.
In research on cell electrophoresis and cell galvanotaxis, methods were developed for
reducing harmful side effects, such as changes in the pH and heterogeneity of the elec-
tric field near the electrodes, changes in the field intensity between the electrodes, toxic
electrode products and gas bubbles. As shown in this study, using previously developed
Grys et al. Cellular & Molecular Biology Letters  (2017) 22:1 Page 11 of 13methods for avoiding the side effects of electric current pulse application to cells also
improves the viability of electroporated cells.
Cell death due to the side effects of electric current pulses acting on cells can be
avoided during electroporation. It is possible to exclude effects related to non-
physiological pH, toxic electrode products and non-uniformity of dcEF intensity fields
acting on the cells by:
1. Placing the cells at a considerable distance from the electrodes and avoiding direct
contact of the cell suspensions with electrodes
2. Separating liquids containing cells from electrodes with dialysis membranes or agar
bridges
3. Using reversible electrodes, preferably Ag/AgCl electrodes
4. Preventing heating of cell suspensions by placing electroporation cuvettes in a water
jacket and decreasing the medium conductivity and Joule’s heat production by the
electric current
Under these conditions, the yield of effective reversible electroporation of cells ex-
ceeds 80%. The side effects of applying electric fields to cells should be decreased or
eliminated, particularly in experiments in which individual cells are investigated.
Abbreviations
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